Precision Biosciences Inc (DTIL)

Feb 24, 2025

Long Term Trading Analysis for (DTIL) - Stock Traders Daily

Feb 24, 2025

Feb 24, 2025

Can This New Gene Editing Approach Transform Duchenne Muscular Dystrophy Treatment? - StockTitan

Feb 24, 2025

Feb 21, 2025

Precision BioSciences (DTIL) Stock Price, News & Analysis - MarketBeat

Feb 21, 2025

Feb 20, 2025

H.C. Wainwright Maintains Buy on Precision BioSciences Stock By Investing.com - Investing.com South Africa

Feb 20, 2025

Feb 20, 2025

H.C. Wainwright Maintains Buy on Precision BioSciences Stock - Investing.com India

Feb 20, 2025

Feb 20, 2025

Precision reports initial outcomes from Hepatitis B trial of PBGENE-HBV - Yahoo Finance

Feb 20, 2025

Feb 20, 2025

Precision BioSciences’ (DTIL) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Feb 20, 2025

Feb 19, 2025

Precision BioSciences Touts Encouraging Initial Safety And Antiviral Activity Of Hepatitis B Treatment Candidate - AOL

Feb 19, 2025

Feb 19, 2025

Breakthrough in Hepatitis B Treatment: Precision BioSciences’ New Hope - Jomfruland.net

Feb 19, 2025

Feb 19, 2025

Precision Biosciences chief research officer sells $49,274 in stock - MSN

Feb 19, 2025

Feb 19, 2025

Precision BioSciences Announces Initial Safety and Antiviral Activity of PBGENE-HBV in the ELIMINATE-B Clinical Trial - BioSpace

Feb 19, 2025

Feb 19, 2025

Precision Bio stock gains on Hep B drug data (DTIL:NASDAQ) - Seeking Alpha

Feb 19, 2025

Feb 19, 2025

Precision Biosciences Announces Initial Safety And Antiviral Activity Of Pbgene-Hbv - Marketscreener.com

Feb 19, 2025

Feb 19, 2025

Revolutionary Gene Therapy Achieves First-Ever ARCUS Success Against Hepatitis BWhat's Next? - StockTitan

Feb 19, 2025

Feb 18, 2025

Precision Biosciences' general counsel sells shares worth $42,765 - MSN

Feb 18, 2025

Feb 10, 2025

Precision BioSciences announces board member's retirement - MSN

Feb 10, 2025

Jan 31, 2025

Precision BioSciences (DTIL) Poised for Growth with ARCUS Technology and Strategic Partnerships - HPBL

Jan 31, 2025

Jan 29, 2025

Precision BioSciences announces board member's retirement By Investing.com - Investing.com Canada

Jan 29, 2025

Jan 29, 2025

Precision BioSciences Strengthens Senior Leadership Team to Drive Multiple In Vivo Gene Editing Programs - BioSpace

Jan 29, 2025

Jan 29, 2025

Precision BioSciences’ Cassie Gorsuch, PhD named CSO - TipRanks

Jan 29, 2025

Jan 28, 2025

Allogene Therapeutics vs. Precision BioSciences: A Deep Dive into Two Promising Gene Therapy Stocks – Market - HPBL

Jan 28, 2025

Jan 26, 2025

Precision Bio rises after gene editing data: BMO upgrades (update) - MSN

Jan 26, 2025

Jan 23, 2025

Precision Biosciences' general counsel sells shares worth $42,765 By Investing.com - Investing.com Canada

Jan 23, 2025

Jan 23, 2025

Precision Biosciences chief research officer sells $49,274 in stock By Investing.com - Investing.com Canada

Jan 23, 2025